Trademarkia Logo

Australia

AU$
NEFSPARRI
Cancelled: Cancelled at the request of IB

Last updated on 12 Feb 2025

Owner Info

Travere Therapeutics, Inc.

3611 Valley Centre Drive,

Suite 300, UNITED STATES OF AMERICA

Serial Number

2291143 filed on 27 Jun 2022

Correspondent

Jared M. Barrett Seed IP Law Group LLP

701 Fifth Avenue, Suite 5400,

Seattle WA 98104,

UNITED STATES OF AMERICA

NEFSPARRI

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis ( Read More

Mark Details


Serial Number

2291143

Registered On

27 Jun 2022

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

23 Jun 2022

Mark Type

US

Legal History


Show more

Status DateAction Taken
12th Feb 2025Status change to Voided
2th Feb 2023International Registration in Australia Protected correspondence sent
1st Feb 2023IP Right Registration Published
1st Feb 2023Status change to Registered/Protected
24th Nov 2022Application Accepted correspondence sent
24th Nov 2022IP Right has been Examined
24th Nov 2022IP Right Acceptance Published
15th Aug 2022Status change to Accepted
12th Aug 2022Examination expedited
12th Aug 2022Awaiting examination